€
E.O. Karaca et al. / Journal of Molecular Structure 1216 (2020) 128351
5
making catalysts in situ opens the way for the discovery of many
new catalysts via the interaction of metal complexes and suitable
ligands. The catalytic advantages of this in situ prepared catalyst
system were investigated in the reduction of imine using i-prop-
anol and t-BuOK under mild reaction conditions. The study results
show that bidentate benzimidazolium salts are much more active
than bidentate imidazolidinium salts in reducing imines. Moreover,
the procedure is simple and effective against various imines.
Detailed investigations focusing on new metal-NHC complexes and
other applications are underway.
eCH2C6H(CH3)3CH2-); 6.88 (s, 4H, CH2C6H2(CH3)3e2,4,6); 4.77 (s,
4H, -CH2C6H(CH3)3CH2-); 4.65 (s, 4H, CH2C6H2(CH3)3e2,4,6); 3.80
and 3.65 (t, J ¼ 9.4 Hz, 8H, NCH2CH2N); 2.50 and 2.29 (s, 9H,
eCH2C6H(CH3)3CH2-); 2.26 and 2.21 (s, 18H, CH2C6H2(CH3)3e2,4,6).
13C{H}NMR (
(-CH2C6H(CH3)3CH2-);
d, CDCl3): 157.1 (NCHN), 138.7, 138.5, 131.8 and 128.7
139.6, 139.4, 130.1 and 127.3
(CH2C6H2(CH3)3e2,4,6); 49.1 (-CH2C6H(CH3)3CH2-); 48.2 and 46.6
(NCH2CH2N); 45.9 (CH2C6H2(CH3)3e2,4,6); 21.4 and 20.3
(CH2C6H2(CH3)3e2,4,6); 20.1 and 16.3 (-CH2C6H(CH3)3CH2-). Anal.
Calc. For C37H50N4Cl2: C, 71.48; H, 8.10; N, 9.01. Found C, 71.50; H,
8.08; N, 9.00.
4. Experimental section
4.2.1.2. 1,10-Bis{(N-2,3,5,6-tetramethylbenzyl)-3,3’-(2,4-dimethylene-
1,3,5-trimethylbenzene)-imidazolidinium chloride, 1b. Yield: 2.66 g;
4.1. Materials
82%. 1H NMR
(d, CDCl3): 9.59 (s, 2H, NCHN); 7.03 (s, 1H,
All reactions for the prepared compounds were carried out
under argon in flame-dried glassware using standard Schlenk
techniques. Chemicals and solvents were purchased from
SigmaeAldrich, and Merck. The solvents used were purified by
distillation over the drying agents indicated and were transferred
under Ar: Et2O (Na/K alloy), CH2Cl2 (P4O10), hexane, toluene (Na).
eCH2C6H(CH3)3CH2-); 6.94 (s, 2H, CH2C6H(CH3)4e2,3,5,6); 5.07 (s,
4H, -CH2C6H(CH3)3CH2-); 4.72 (s, 4H, CH2C6H(CH3)4e2,3,5,6); 4.05
and 3.73 (t, J ¼ 9.9 Hz, 8H, NCH2CH2N); 2.55 and 2.31 and (s, 9H,
eCH2C6H(CH3)3CH2-);
2.21
and
2.19
(s,
24H,
CH2C6H(CH3)4e2,3,5,6). 13C{H}NMR (
d, CDCl3): 157.2 (NCHN), 139.6,
139.1, 131.5 and 128.7 (-CH2C6H(CH3)3CH2-); 134.5, 133.9, 132.4 and
127.6 (CH2C6H(CH3)4e2,3,5,6); 49.1 (-CH2C6H(CH3)3CH2-); 47.5 and
46.9 (NCH2CH2N); 46.7 (CH2C6H(CH3)4e2,3,5,6); 20.5 and 15.9
(CH2C6H(CH3)4e2,3,5,6); 19.9 and 16.7 (-CH2C6H(CH3)3CH2-). Anal.
Calc. For C39H54N4Cl2: C, 72.09; H, 8.38; N, 8.62. Found C, 72.15; H,
8.42; N, 8.59.
4.1.1. NMR spectroscopy
1H NMR and 13C NMR spectra were recorded using a Varian As
300 Merkur spectrometer operating at 300 MHz (1H), 75 MHz (13C)
in CDCl3 and DMSO‑d6 with tetramethylsilane as an internal
reference. The NMR studies were carried out in high-quality 5 mm
NMR tubes. Signals are quoted in parts per million as
d
downfield
4.2.1.3. 1,10-Bis{(N-2,3,4,5,6-pentamethylbenzyl)-3,3’-(2,4-
from tetramethylsilane ( 0.00) as an internal standard. Coupling
d
dimethylene-1,3,5-trimethylbenzene)-imidazolidinium chloride, 1c.
constants (J values) are given in hertz. NMR multiplicities are
abbreviated as follows: s ¼ singlet, d ¼ doublet, t ¼ triplet,
m ¼ multiplet signal.
Yield: 2.94 g; 87%. 1H NMR (
d, CDCl3): 9.63 (s, 2H, NCHN); 7.03 (s,
1H, eCH2C6H(CH3)3CH2-); 5.06 (s, 4H, -CH2C6H(CH3)3CH2-); 4.71 (s,
4H, CH2C6(CH3)5e2,3,4,5,6); 4.05 and 3.71 (t, J ¼ 9.9 Hz, 8H,
NCH2CH2N); 2.51 and 2.32 (s, 9H, eCH2C6H(CH3)3CH2-); 2.25, 2.21
4.1.2. Elemental analyse
and 2.19 (s, 30H, CH2C6(CH3)5e2,3,4,5,6). 13C{H}NMR (
d, CDCl3):
Elemental analyses were performed by LECO CHNS-932
elementary chemical analyser.
157.1 (NCHN), 139.4, 139.2, 131.7 and 127.6 (-CH2C6H(CH3)3CH2-);
136.1, 133.4, 133.3 and 125.9 (CH2C6(CH3)5e2,3,4,5,6); 49.1
(-CH2C6H(CH3)3CH2-); 47.5 and 47.2 (NCH2CH2N); 46.9
(CH2C6(CH3)5e2,3,4,5,6); 20.0 and 18.4 (-CH2C6H(CH3)3CH2-), 17.2,
16.9 and 16.7 (CH2C6(CH3)5e2,3,4,5,6). Anal. Calc. For C41H58N4Cl2:
C, 72.65; H, 8.62; N, 8.27. Found C, 72.69; H, 8.65; N, 8.31.
4.1.3. Gas chromatography
All reactions were monitored on an Agilent 6890 N GC system by
GC-FID with an HP-5 column of 30 m length, 0.32 mm diameter and
0.25 mm film thickness.
4.2.2. Synthesis of bidentate benzimidazolium salts
4.1.4. Gas chromatography-mass spectroscopy
All catalytic reactions were monitored on a Shimadzu 2010 Plus
GC-MS system by GC-FID with an HP-5 column of 30 m length,
4.2.2.1. General synthesis method for bisbenzimidazolidinium salts
(2a-c). To a solution of 1-alkylbenzimidazole (10 mmol) in DMF
was slowly added 2,4-bischloromethyl-1,3,5-trimethylbenzene
(5 mmol) and stirred at 25 ꢀC for 5 h. The resulting mixture was
heated at 80 ꢀC for 10 h. Diethylether (10 mL) was added to the
cooled solution to precipitate the white solid. The crude product
was filtered, washed with diethylether (3 ꢁ 5 mL) and dried in
vacuum. Recrystallized in ethanol/diethyl ether solvent mixture.
0.32 mm diameter and 0.25
mm film thickness.
4.1.5. Column chromatography
Column chromatography was performed using silica gel 60
(70e230 mesh). Solvent ratios are given as v/v.
4.2. Synthesis of bidentate imidazolidinium salts
4.2.2.2. 1,10-Bis(N-(3,4,5-trimethoxybenzyl)-3,3’-(2,4-dimethylene-
1,3,5-trimethylbenzene)-benzimidazolium chloride, 2a. Yield: 3.35 g;
4.2.1. General synthesis method for bisimidazolidinium salts (1a-c)
85%. 1H NMR (
d
, CDCl3): 10.97 (s, 2H, NCHN); 8.25 (d, J ¼ 8.4 Hz, 2H,
To the solution of 1-alkylimidazolidine (10 mmol) in DMF was
NC6H4N); 7.69e7.53 (m, 6H, NC6H4N); 7.14 (s, 1H,
eCH2C6H(CH3)3CH2-); 6.74 (s, 4H, CH2C6H2(OCH3)3-3,4,5); 5.84 and
5.80 (s, 8H, -CH2C6H(CH3)3CH2- and CH2C6H2(OCH3)3-3,4,5);3.74 and
3.73 (s, 18H, CH2C6H2(OCH3)3-3,4,5); 2.31 and 2.24 (s, 9H,
slowly
added
2,4-bischloromethyl-1,3,5-trimethylbenzene
(5 mmol) and stirred at 25 ꢀC for 2 h. The resulting mixture was
heated at 80 ꢀC for 8 h. When diethyl ether (15 mL) was added, the
resulting white crystals were filtered, washed with diethyl ether
(3 ꢁ 15 mL) and dried in vacuum. The crude product was recrys-
tallized from EtOH/Et2O.
CH2C6H(CH3)3CH2). 13C{H}NMR (
d, CDCl3): 162.7 (NCHN), 142.2,
140.9,140.3,129.3, and 127.2(-CH2C6H(CH3)3CH2-),132.0,131.8,127.7,
127.6, 114.4 and 114.0 (NC6H4N); 153.9, 138.6, 132.6 and 106.1
(CH2C6H2(OCH3)3-3,4,5); 60.9 and 56.7 (CH2C6H2(OCH3)3-3,4,5);
53.6, 51.5 and 46.8 (CH2C6H2(OCH3)3-3,4,5 and -CH2C6H(CH3)3CH2-);
20.2 and 17.2 (-CH2C6H(CH3)3CH2-). Anal. Calc. For. C45H50N4O6Cl2: C,
66.41; H, 6.19; N, 6.88. Found C, 66.45; H, 6.23; N, 6.85.
4.2.1.1. 1,10-Bis{(N-2,4,6-trimethylbenzyl)-3,3’-(2,4-dimethylene-
1,3,5-trimethylbenzene)-imidazolidinium chloride, 1a. Yield: 2.45 g;
80%. 1H NMR
(d, CDCl3): 9.03 (s, 2H, NCHN); 7.05 (s, 1H,